Zooming in additional, there’s one specific kind of insulating materials positioned between the chip and the construction beneath it; this materials, known as dielectric movie, is produced in sheets as skinny as white blood cells.
For 30 years, a single Japanese firm known as Ajinomoto has made billions producing this specific movie. Opponents have struggled to outdo them, and as we speak Ajinomoto’s merchandise are utilized in all the things from laptops to information facilities.
Now, a startup based mostly in Berkeley, California, is embarking on a herculean effort to dethrone Ajinomoto and produce this small slice of the chipmaking provide chain again to the US. However success is way from assured. Read the full story.
—James O’Donnell
The trouble to make a breakthrough most cancers remedy cheaper
CAR-T therapies, created by engineering a affected person’s personal cells to battle most cancers, are usually reserved for individuals who have exhausted different remedy choices. However final week, the FDA authorised Carvykti, a CAR-T product for a number of myeloma, as a second-line remedy. Meaning individuals are eligible to obtain Carvykti after their first relapse.
Whereas this implies some a number of myeloma sufferers within the US will now get earlier entry to CAR-T, the overwhelming majority of sufferers across the globe nonetheless received’t get CAR-T in any respect. These therapies are costly—half one million {dollars} in some instances. However have they got to be? Read the full story.
